LGM Pharma Acquires Nexgen Pharma's Drug Product CDMO Business
July 23, 2020
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, expanding LGM's CDMO capabilities and U.S.-based manufacturing footprint. Financial support for the transaction was provided by private equity firm New Harbor Capital; Nexgen Pharma sold its pharmaceutical CDMO unit to allow the company to focus on other healthcare segments.
- Buyers
- LGM Pharma, New Harbor Capital
- Targets
- Nexgen Pharma (formulation development and drug product contract manufacturing business)
- Sellers
- Nexgen Pharma
- Industry
- Pharmaceuticals
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.